Panacea
ActiveAI-Native FDA Regulatory Services
About
Panacea provides AI-native FDA regulatory services for Biotechs and Medical Device companies. We hire the most experienced FDA consultants in the industry (ex-FDA, decades of experience, hundreds of filings) and pair them with our AI platform to enable the fastest and lowest cost pathway to FDA approval. While other regulatory consultants bill hourly, our pricing model is simple: fixed, outcome-based pricing. Payment is only due when milestones are complete. We support all FDA regulatory pathways including IND, NDA, BLA, ODD, Pre-Subs, 510(k), De Novo, PMA, IDE, BDD, etc.
Founders · 2
ex-GTM (Partnerships Lead) @ Anterior - backed by Sequoia, NEA and Microsoft AI's CEO. MD, Imperial College Medical School, Imperial College Business School.
Founder & CTO at Panacea (YC P26). Previously AI Platform Engineer at Anterior, building AI infrastructure for health insurers with millions of members. Co-founded Baqi, scaling to $3M+ in transactions and 20+ enterprise partnerships. Built large-scale distributed systems at Bloomberg, leading multi-team regulatory compliance projects. BS/MS in CS and AI from UIC.
Launch
The best FDA consultants, paired with AI, for faster & lower-cost FDA filings.
Panacea hires elite FDA regulatory consultants and pairs them with an AI platform to deliver faster, lower-cost FDA filings for biotechs and medtechs, with fixed milestone-based pricing and a focus on the regulatory submission process.
Related startups
AI Licensing Agent for Regulated Industries
Full stack AI Agents accelerating Biopharma R&D
